{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:53:48Z","timestamp":1715972028622},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T00:00:00Z","timestamp":1109289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Cardiovascular mortality is increased in patients with hypopituitarism. Elevated concentrations of the endogenous NO synthase antagonist asymmetrical dimethylarginine (ADMA) may be related to the development of atherosclerosis and are associated with cardiovascular risk. We studied the concentrations of ADMA in hypopituitary patients with and without growth hormone deficiency (GHD) and in healthy subjects.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> Plasma from 44 patients with hypopituitarism with (<jats:italic>n<\/jats:italic>\u00a0=\u00a030) and without GHD (<jats:italic>n<\/jats:italic>\u00a0=\u00a014) and from 25 age\u2010 and sex\u2010matched healthy controls was taken for analysis of <jats:sc>l<\/jats:sc>\u2010arginine, ADMA, symmetrical dimethylarginine (SDMA) and clinical parameters. Further plasma from 10 hypopituitary patients was examined before and after treatment with 9\u00a0g of oral <jats:sc>l<\/jats:sc>\u2010arginine for 14\u00a0days.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Asymmetrical dimethylarginine was significantly higher in the hypopituitary patients than in the controls (0\u00b763\u00a0\u00b1\u00a00\u00b712 vs. 0\u00b751\u00a0\u00b1\u00a00\u00b715\u00a0\u00b5mol\u00a0L<jats:sup>\u22121<\/jats:sup>; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7005). <jats:sc>l<\/jats:sc>\u2010arginine and the <jats:sc>l<\/jats:sc>\u2010arginine\/ADMA ratios were lower in the subjects with hypopituitarism (53\u00a0\u00b1\u00a018 vs. 90\u00a0\u00b1\u00a029\u00a0\u00b5mol\u00a0L<jats:sup>\u22121<\/jats:sup> and 87\u00a0\u00b1\u00a031 vs. 185\u00a0\u00b1\u00a059; both <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b70001). Symmetrical dimethylarginine was comparable between the patients and the controls. <jats:sc>l<\/jats:sc>\u2010arginine and dimethylarginines were associated with 2\u2010h stimulated glucose levels in a glucose tolerance test (<jats:italic>r\u00a0=<\/jats:italic>\u00a00\u00b733; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b705), but not other cardiovascular risk factors. Oral <jats:sc>l<\/jats:sc>\u2010arginine supplementation normalized the reduced <jats:sc>l<\/jats:sc>\u2010arginine\/ADMA ratio in the hypopituitary patients.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Asymmetrical dimethylarginine is elevated in patients with hypopituitarism independent of GHD and traditional risk factors. This might contribute to the increased cardiovascular morbidity in hypopituitary patients.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2005.01474.x","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T11:24:20Z","timestamp":1109330660000},"page":"208-213","source":"Crossref","is-referenced-by-count":12,"title":["Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency"],"prefix":"10.1111","volume":"35","author":[{"given":"K.","family":"Krzyzanowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mittermayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wolzt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schernthaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91812-O"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04006-X"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.2.574"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee","volume":"83","author":"Carroll PV","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_5_7_2","first-page":"37","article-title":"Long\u2010term effects of growth hormone therapy on intermediary metabolism and insulin sensitivity in hypopituitary adults","volume":"22","author":"Johnston DG","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92892-J"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90585-D"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-6374(99)80006-9"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119095"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00671.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.9.4223"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.4.520"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5688(03)00032-1"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90865-Z"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199904000-00020"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.11.1420"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.765"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02063-X"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20030363"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.9.2032"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0916-4"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2003.50048"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.311"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000027109.14149.67"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.24.3092"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348199"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.12.5774"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V131170"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)07184-7"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1191\/1358863x03vm474oa"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00617-X"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-6374(02)00119-3"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00910.x"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2004.04.010"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200308000-00006"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2005.01474.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2005.01474.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:26:39Z","timestamp":1697214399000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2005.01474.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,25]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1365-2362.2005.01474.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01474.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,25]]}}}